Pharma

Gufic Biosciences Ltd

GUFICBIO · NSE · INE742B01025
₹429.9-2.37%consolidatedstandalone
Wednesday, 9 Sept 2026Vol: 6.9L traded · 29.8% delivered11:32 am
Sentiment81 · Extreme Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap₹4,265 Cr
P/E58.1
P/B6.4
EPS₹7.31
Div Yield0.0%
ROE10.1%
ROCE12.3%
ROE10.1%
1Y Return+39.01%
Avg. Volume0.1M
Delivery %29.76%

Price Chart

43939735531327141.7L83.5LSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026May 2026Jul 2026Sept 2026

52-Week Range

₹268₹429.9₹467.8
52W Low52W High

About

Gufic Biosciences Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap₹4,265 Cr
Current Price₹429.9
52W High / Low₹467.8 / ₹268
Stock P/E58.1
Price to Book6.4
EPS (TTM)₹7.31
Dividend Yield0.0%
ROE10.1%
1Y Return+39.01%
Day Change-2.37%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23
Sales₹981 Cr₹944 Cr₹820 Cr
Expenses₹816 Cr₹793 Cr₹684 Cr
Operating Profit₹165 Cr₹151 Cr₹136 Cr
OPM %17.0%16.0%17.0%
Other Income₹2 Cr₹3 Cr₹4 Cr
Depreciation₹31 Cr₹31 Cr₹21 Cr
Interest₹37 Cr₹37 Cr₹25 Cr
Profit Before Tax₹99 Cr₹87 Cr₹94 Cr
Tax₹26 Cr₹23 Cr₹24 Cr
Net Profit₹73 Cr₹64 Cr₹70 Cr
EPS (₹)7.36.47.0
Dividend Payout %—2%1%
Financial history locked

Register free to see 2 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
Sales₹261 Cr₹252 Cr₹231 Cr₹237 Cr
Expenses₹214 Cr₹205 Cr₹198 Cr₹199 Cr
Operating Profit₹47 Cr₹47 Cr₹33 Cr₹38 Cr
OPM %18.0%19.0%14.0%16.0%
Depreciation₹8 Cr₹8 Cr₹8 Cr₹8 Cr
Interest₹9 Cr₹9 Cr₹8 Cr₹10 Cr
Net Profit₹22 Cr₹22 Cr₹12 Cr₹17 Cr
EPS (₹)2.22.21.21.7
Quarterly history locked

Register free to see 8 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23
Liabilities
Equity Capital₹10 Cr₹10 Cr₹10 Cr
Reserves₹655 Cr₹591 Cr₹523 Cr
Borrowings₹405 Cr₹336 Cr₹333 Cr
Other Liabilities₹272 Cr₹232 Cr₹227 Cr
Total Liabilities₹1,342 Cr₹1,169 Cr₹1,093 Cr
Assets
Fixed Assets₹491 Cr₹506 Cr₹159 Cr
Investments₹2 Cr₹2 Cr₹2 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹827 Cr₹640 Cr₹625 Cr
Total Assets₹1,342 Cr₹1,169 Cr₹1,093 Cr
Balance sheet history locked

Register free to see 2 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹45 Cr₹-31 Cr₹32 Cr₹46 Cr
FY25₹123 Cr₹-71 Cr₹-37 Cr₹15 Cr
FY24₹-7 Cr₹-102 Cr₹82 Cr₹-27 Cr
FY23
Cash flow history locked

Register free to see 2 more years.

Register free

Shareholding Pattern

Quarterly Trend

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Sun Pharmaceutical Industries Ltd——+14.78%+7.18%
Dr Reddys Laboratories Ltd——+8.84%-3.74%
Cipla Ltd——+11.77%-5.50%
Apollo Hospitals Enterprise Ltd——+22.64%+23.01%
Divis Laboratories Ltd₹2,50,065 Cr83.9+16.5%+46.29%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-08Announcement under Regulation 30 (LODR)-Credit RatingBSE Filing2026-08-19Gufic Biosciences Ltd (BOM:509079) (Q1 2027) Earnings Call Highlights: Margin Expansion and ...GuruFocus.com2026-06-09Gufic Biosciences Ltd (BOM:509079) Q4 2026 Earnings Call Highlights: Record Revenue and ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.